Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

UK Gastrointestinal Remedies market report

Everything you need to make the right decisions

Providing the most comprehensive and up-to-date information and analysis of the Gastrointestinal Remedies market, its consumers and the major players who make up that market.

Mintel has the answers you’re looking for

  • What are the key challenges facing the industry?
  • Who is the consumer and what do they want?
  • Where are the opportunities, where are the risks and what lies ahead?

Market

Point of sale market data

In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money on

Market Size

How big is the market today and what is our 5 year forecast? Includes both best & worst case scenarios

Market Segmentation

What are the different segments within the market and how are those individual segments performing?

Consumer

Consumer behaviors

What are consumers looking for, what drives their buying habits and what are their main purchase influencers?

Demographic breakdown

From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?

Representative sample

We gather our data from real-world consumers, selected to accurately reflect precise global demographics

Players

Company strategy

What are the key players doing, what has been successful for them and what was their marketing spend?

Product innovation

Using data from our Global New Product Database, what products were launched and how well were they perceived?

Opportunities

What happens next, which areas are likely to experience growth and what opportunities exist within the market?

Covered in this report

This report analyses the market for all types of indigestion and stomach remedies available over the counter, which together constitute the GI remedies market.

The five main categories are as follows:

Indigestion/heartburn remedies range from simple antacids such as Rennie or wind relief such as Setlers or Wind-eze to more potent medication such as Gaviscon or Zantac.

Laxatives relieve constipation and work in one of several ways, either by introducing fibre to the bowel, stimulating the bowel or softening stools.

Anti-diarrhoeals are usually opiate-based to slow down the movement of waste through the bowel, and/or contain kaolin to add bulk to waste and neutralise bacteria. This segment also includes rehydrating solutions, or electrolyte solutions, which replace the fluid and salts lost when suffering from diarrhoea.

Stomach upset remedies, for example, Alka-Seltzer or Andrews, relieve nausea and settle the stomach.

IBS products provide symptomatic relief for the spasms and bloating which are typical of IBS. Many of these products, such as Colpermin, are based on peppermint oil, which is naturally soothing for gastrointestinal problems.

This report covers only OTC (over-the-counter) (non-prescription) medication, defined by the Proprietary Association of Great Britain as being:

“Specifically designed to treat the symptoms of common, minor and self-limiting ailments that do not require a medical diagnosis.”

They are divided into two categories:

P: Pharmacy-only products, which can only be sold through pharmacies by, or in the presence of, a qualified pharmacist.

GSL: General Sales List, which can be sold in any type of outlet.

Prescription-only Medicines (POMs), which have to be prescribed by a GP (General Practitioner) and dispensed by a qualified pharmacist, are not included within the scope of this Report.

What you need to know

The GI (gastrointestinal) remedies market is forecast to continue on its growth trajectory in 2018, with value sales rising to an expected £308 million from £300 million in 2017.

Although the market is broadly a mature one, marked by low levels of true NPD (New Product Development), pockets of faster growth remain. For example, remedies for IBS (irritable bowel syndrome) represent a growth area, as more people are diagnosed – or indeed self-diagnose – with the condition, whilst rising levels of stress are expected to drive GI complaints and subsequently sales of products to help ease symptoms.

Expert analysis from a specialist in the field

Written by Hera Crossan, a leading analyst in the Health & Wellness sector, her extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.

In a mature market, finding growth can be a challenge. Gastrointestinal remedies has faced this issue, but brands have benefited from an increase in consumers seeking to alleviate GI symptoms arising from stress, IBS and shifts in dietary habits. With these issues likely to continue, the market is set to see continued investment from those who appear to prefer the convenience of addressing symptoms over tackling root causes.Hera Crossan
Health & Wellness Analyst

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Overview

    • What you need to know
      • Products covered in this Report
      • Executive Summary

          • The market
            • Strong growth continues – for now
              • Figure 1: Best- and worst-case forecast of UK value sales of gastrointestinal remedies, 2013-23
            • Companies and brands
              • Pockets of faster growth emerge
                • Figure 2: UK brand shares in value sales of gastrointestinal remedies, year ending July 2018
              • The consumer
                • Gastrointestinal issues widespread
                  • Figure 3: Gastrointestinal health issues experienced in the last 6 months, October 2018
                • General OTC remedies more popular than GI remedies
                  • Figure 4: Treatments sought in the last 6 months, October 2018
                • Stress as the leading cause of GI ill health
                  • Figure 5: Causes of gastrointestinal health problems, October 2018
                • Few adults come prepared
                  • Figure 6: Behaviours around gastrointestinal health and remedies, October 2018
                • Remedies easier than lifestyle changes
                  • Figure 7: Attitudes towards gastrointestinal health and remedies, October 2018
                • What we think
                • Issues and Insights

                  • Rising stress levels affecting GI health
                    • The facts
                      • The implications
                      • The Market – What You Need to Know

                        • Strong growth continues – for now
                          • IBS remedies see boost in value
                            • Chemists enjoy substantial market share
                              • Growth in older consumers a boon for indigestion remedies
                                • ‘Free-from’ market on the rise
                                  • Obesity levels continue to increase
                                    • Millennials drinking less
                                      • Stress contributing to GI issues
                                      • Market Size and Forecast

                                        • Strong growth continues…
                                          • Figure 8: UK retail value sales of gastrointestinal remedies, at current and constant prices, 2013-23
                                        • …but is forecast to slow
                                          • Figure 9: Best- and worst-case forecast of UK value sales of gastrointestinal remedies, 2013-23
                                        • Forecast methodology
                                        • Market Segmentation

                                          • Indigestion and IBS remedies drive growth
                                            • Figure 10: UK retail value sales of gastrointestinal remedies, by segment, 2016-18
                                        • Channels to Market

                                          • Chemists enjoy substantial market share
                                            • Figure 11: UK retail value sales of gastrointestinal remedies, by outlet type, 2016-18
                                        • Market Drivers

                                          • Growth in older consumers a boon for indigestion remedies
                                            • Figure 12: Trends in the age structure of the UK population, 2013-23
                                          • Norovirus makes its mark
                                            • Cuts to NHS Minor Ailments Scheme could aid sales
                                              • Figure 13: Number of gastrointestinal prescription items dispensed, 2008-17
                                            • ‘Free-from’ market on the rise
                                              • Obesity levels continue to increase
                                                • Figure 14: Trends in BMI, England, 1995-2016
                                              • Millennials drinking less
                                                • Figure 15: Drinking frequency in the week before the interview, Great Britain, by age, 2005-17
                                              • International travel recovers past pre-recession levels
                                                • Figure 16: UK residents’ visits abroad (thousands), 1997-2017
                                              • Ethnic restaurants and takeaways rise in popularity
                                                • Stress contributing to GI issues
                                                  • Figure 17: Causes of stress over last 12 months, February 2018
                                              • Companies and Brands – What You Need to Know

                                                • Pockets of faster growth emerge
                                                  • True NPD remains low
                                                    • Own-label now well established
                                                      • GI remedies market sees rise of ‘free-from’ claims
                                                        • Gaviscon still top dog by adspend
                                                          • Adspend falls as NPD stagnates
                                                          • Market Share

                                                            • Pockets of faster growth emerge
                                                              • Figure 18: Brand shares in gastrointestinal remedies, years ending July 2017 and 2018
                                                            • Own-label value slips
                                                            • Launch Activity and Innovation

                                                              • True NPD remains low
                                                                • Figure 19: NPD in the gastrointestinal remedies market, by launch type, January 2015-August 2018
                                                                • Figure 20: Examples of new packaging in gastrointestinal remedy launches, 2017-18
                                                              • Tablets take lion’s share of NPD
                                                                • Figure 21: NPD in the gastrointestinal remedies market, by format type, January 2015-August 2018
                                                                • Figure 22: Examples of capsule format in gastrointestinal remedy launches, 2017
                                                              • Own-label now well established
                                                                • Figure 23: NPD in the gastrointestinal remedies market, branded vs own-label, January 2015-August 2018
                                                                • Figure 24: Examples of own-label gastrointestinal remedy launches, 2017-18
                                                              • GI remedies market sees rise of ‘free-from’ claims
                                                                • Figure 25: Top 10 claims in the UK gastrointestinal remedies market (based on leading claims for 2017), 2016 and 2017
                                                                • Figure 26: Examples of gastrointestinal remedy launches with free-from claims, 2017-18
                                                            • Advertising and Marketing Activity

                                                              • Adspend falls as NPD stagnates
                                                                • Figure 27: Total above-the-line, online display and direct mail advertising expenditure on gastrointestinal remedies, January 2015-August 2018
                                                              • Adspend decreases across the board
                                                                • Figure 28: Total above-the-line, online display and direct mail advertising expenditure on gastrointestinal remedies, by top advertisers (based on 2017), January 2015-August 2018
                                                              • Gaviscon still top dog by adspend
                                                                • Figure 29: Total above-the-line, online display and direct mail advertising expenditure on gastrointestinal remedies, by top brands, 2017
                                                              • TV remains the best way to access consumers
                                                                • Figure 30: Total above-the-line, online display and direct mail advertising expenditure on gastrointestinal remedies, by media type, January 2015-August 2018
                                                                • Figure 31: Gaviscon ‘Go On’ campaign, July 2018
                                                              • Nielsen Ad Intel coverage
                                                              • The Consumer – What You Need to Know

                                                                • Young women suffer stress-induced issues
                                                                  • General OTC remedies more popular than GI remedies
                                                                    • Men struggle with emotional aspect of GI health
                                                                      • Few adults come prepared
                                                                        • Under-35s believe in detoxing…
                                                                          • …though remedies easier than lifestyle changes
                                                                          • Types of Ailments Experienced

                                                                            • Young women suffer stress-induced issues
                                                                              • Figure 32: Gastrointestinal health issues experienced in the last 6 months, October 2018
                                                                          • Treatments Sought

                                                                            • General OTC remedies more popular than GI remedies
                                                                              • Figure 33: Treatments sought in the last 6 months, October 2018
                                                                            • Managing through diet
                                                                            • Causes of Gastrointestinal Health Problems

                                                                              • Stress as the leading cause of GI ill health
                                                                                • Figure 34: Causes of gastrointestinal health problems, October 2018
                                                                              • Poor diet and lack of sleep as additional leading lifestyle factors
                                                                                • One in 10 feel the impact of viruses
                                                                                • Behaviours around Gastrointestinal Health and Remedies

                                                                                  • Young adults need guidance
                                                                                    • Figure 35: Behaviours around gastrointestinal health and remedies, October 2018
                                                                                  • Few adults come prepared
                                                                                    • Total wellbeing plays a role for GI health
                                                                                    • Attitudes towards Gastrointestinal Health and Remedies

                                                                                      • Men struggle with emotional aspect of GI health
                                                                                        • Figure 36: Attitudes towards gastrointestinal health and remedies, October 2018
                                                                                      • Under-35s believe in detoxing…
                                                                                        • …though remedies still seen as easier than lifestyle changes
                                                                                        • Appendix – Data Sources, Abbreviations and Supporting Information

                                                                                            • Abbreviations
                                                                                              • Consumer research methodology
                                                                                                • Forecast methodology